During the opening day of the BioHealth Capital Region Forum at US Pharmacopeia in Rockville on September 17th, 2024, Virginia Governor Glenn Youngkin was awarded the 2024 Governor of the Year by the Biotechnology Innovation Organization (BIO). This prestigious award recognizes governors who have demonstrated strong leadership and commitment to advancing biotechnology in their states.
Governor Youngkin, who has been instrumental in driving economic development across Virginia, spoke about the Commonwealth’s expanding role in the life sciences sector. “Investing in biotechnology is investing in Virginia’s future,” he remarked, highlighting the importance of Virginia’s research triangle and ongoing efforts to foster innovation. Under his leadership, Virginia has secured nearly $71 billion in capital investments, transforming the state into a significant hub for biotechnology and other industries.
BIO President and CEO John F. Crowley, a long-time advocate for biotechnology, presented the award. Crowley praised Governor Youngkin for his dedication to advancing Virginia’s bioscience ecosystem, stating, “His leadership has helped create opportunities for researchers, entrepreneurs, and patients, positioning Virginia as a key player in the life sciences.” Crowley, who has a personal connection to the biotech industry through his work to find treatments for Pompe disease, commended the Governor’s vision and impact on public policy.
John Newby, CEO of the Virginia Biotechnology Association, also lauded Youngkin’s support, noting how the Governor’s initiatives have bolstered partnerships and innovation in Virginia’s $8 billion biotechnology industry.
“Congratulations to Governor Youngkin on being named BIO’s Governor of the Year, a well-deserved recognition for his leadership and commitment to advancing biotechnology in Virginia,” said Rich Bendis, President and CEO of BioHealth Innovation, Inc. “We’re honored that BIO chose the BioHealth Capital Region Forum as the platform to present this prestigious award, further highlighting the importance of our region as a thriving hub for innovation and collaboration in the life sciences.”
The presentation of the award was a highlight of the Forum, which brought together leaders from across the biohealth sector. Governor Youngkin’s recognition underscores Virginia’s crucial role in the broader BioHealth Capital Region, contributing to the region’s continued growth as a top biohealth cluster in the United States.